Rabat — Morocco’s Ministry of Health and Social Protection has lowered the prices of several key medicines. These include treatments for mental health, Alzheimer’s disease, and hormonal disorders.
The move aims to make essential drugs more affordable and easier to access for patients nationwide.
The new prices were announced in the Official Gazette after a detailed review of original, generic, and biosimilar drugs available in Morocco. The ministry examined pricing requests from pharmaceutical companies and adjusted costs for both public and hospital sectors.
One of the medicines affected is Almantin 10 mg, commonly used to treat Alzheimer’s disease. Its price for the general public has dropped from MAD 140.40 ($14.00) to MAD 133.30 ($13.30). The hospital price was reduced from MAD 87.70 ($8.70) to MAD 83.30 ($8.30).
Related Topics
